Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP

被引:36
|
作者
Cui, Qian-Qian [1 ]
Hu, Zhuang-Li [1 ,2 ,3 ,4 ]
Hu, Yuan-Lang [1 ]
Chen, Xi [1 ]
Wang, Ji [1 ]
Mao, Li [1 ]
Lu, Xiao-Jia [1 ]
Ni, Ming [1 ]
Chen, Jian-Guo [1 ,2 ,3 ,4 ,5 ]
Wang, Fang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pharmacol, Wuhan, Peoples R China
[2] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Inst Brain Res, Lab Neuropsychiat Dis, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Res Ctr Depress, Wuhan, Peoples R China
[5] Minist Educ China, Key Lab Neurol Dis HUST, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
ATP; CD39; CSDS; neurogenesis; spine; SOCIAL DEFEAT STRESS; SYNAPTIC PLASTICITY; SPINE DENSITY; NEUROGENESIS; RECEPTOR; ANXIETY; DEFICIENCY; EXPRESSION; STABILITY; GLUTAMATE;
D O I
10.15252/embr.201947857
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence implicates that low levels of ATP in the extracellular space may contribute to the pathophysiology of major depressive disorder (MDD). The concentration of extracellular ATP is regulated by its hydrolase ectonucleotide tri(di)phosphohydrolase (ENTPD). However, the role of ENTPD in depression remains poorly understood. Here we examine the role of CD39 (known as ENTPD1) in mouse depression-like behavior induced by chronic social defeat stress (CSDS). We demonstrate that CSDS enhances the expression and activity of CD39 in hippocampus. The CD39 functional analog apyrase also induces depression-like behavior, which can be ameliorated by ATP replenishment. Pharmacological inhibition and genetic silencing of CD39 has an antidepressant-like effect via increasing hippocampal extracellular ATP concentration, accompanied with an increase in hippocampal neurogenesis and dendritic spine numbers in defeated mice. These results suggest that hippocampal CD39 contributes to CSDS-induced depression-like behavior via hydrolyzing extracellular ATP, indicating that CD39 may be a promising new target for the treatment of depression.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Transcription factor YY1 and the retinoblastoma protein are downstream targets of CD39/ENTPD1 signaling pathways during liver regeneration
    Wu, Y
    Imai, M
    Sun, XF
    Csizmadia, E
    Enjyoji, K
    Choi, CH
    Robson, SC
    Usheva, A
    HEPATOLOGY, 2005, 42 (04) : 642A - 643A
  • [32] ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
    Rodney P. Rocconi
    Laura Stanbery
    Min Tang
    Luciana Madeira da Silva
    Adam Walter
    Bradley J. Monk
    Thomas J. Herzog
    Robert L. Coleman
    Luisa Manning
    Gladice Wallraven
    Staci Horvath
    Ernest Bognar
    Neil Senzer
    Scott Brun
    John Nemunaitis
    Communications Medicine, 2
  • [33] A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model
    Adhikary, Sam R.
    Cuthbertson, Peter
    Turner, Ross J.
    Sluyter, Ronald
    Watson, Debbie
    IMMUNOLOGY AND CELL BIOLOGY, 2020, 98 (05): : 397 - 410
  • [34] Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior
    Abe-Higuchi, Naoko
    Uchida, Shusaku
    Yamagata, Hirotaka
    Higuchi, Fumihiro
    Hobara, Teruyuki
    Hara, Kumiko
    Kobayashi, Ayumi
    Watanabe, Yoshifumi
    BIOLOGICAL PSYCHIATRY, 2016, 80 (11) : 815 - 826
  • [35] SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sezary patients
    Luo, Yixin
    Tensen, Kees
    Zoutman, Willem
    Najidh, Safa
    Quint, Koen
    Vermeer, Maarten
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S16 - S16
  • [36] Expression of CD39/Entpd1 on granuloma-composing cells and induction of Foxp3-positive regulatory T cells in sarcoidosis
    Fujimura, T.
    Kambayashi, Y.
    Aiba, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (08) : 883 - 889
  • [37] ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Cell Carcinoma
    Whitley, Melodi Javid
    Suwanpradid, Jutamas
    Lai, Chester
    Jiang, Simon W.
    Cook, Jonathan L.
    Zelac, Daniel E.
    Rudolph, Ross
    Corcoran, David L.
    Degan, Simone
    Spasojevic, Ivan
    Levinson, Howard
    Erdmann, Detlev
    Reid, Claire
    Zhang, Jennifer Y.
    Robson, Simon C.
    Healy, Eugene
    Havran, Wendy L.
    Macleod, Amanda S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : 2509 - 2520
  • [38] DELETION OF CD39/ENTPD1 UNVEILS MAJOR DIFFERENCES IN THE MECHANISMS UNDERLYING REJECTION OF TRANSPLANTED VS. GROWTH OF AUTOCHTHONOUS HEPATIC TUMORS
    Wu, Yan
    Sun, Xiaofeng
    Han, Lihui
    Usheva, Anny
    Csizmadia, Eva
    Robson, Simon C.
    HEPATOLOGY, 2010, 52 (04) : 603A - 603A
  • [39] Expression and function of P2X7 receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters
    Garcia-Hernandez, Mariana H.
    Portales-Cervantes, Liliana
    Cortez-Espinosa, Nancy
    Vargas-Morales, Juan M.
    Fritche Salazar, Juan F.
    Rivera-Lopez, Emmanuel
    Rodriguez-Rivera, Javier G.
    Quezada-Calvillo, Roberto
    Portales-Perez, Diana P.
    CELLULAR IMMUNOLOGY, 2011, 269 (02) : 135 - 143
  • [40] Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
    Rodney P. Rocconi
    Laura Stanbery
    Min Tang
    Luciana Madeira da Silva
    Adam Walter
    Bradley J. Monk
    Thomas J. Herzog
    Robert L. Coleman
    Luisa Manning
    Gladice Wallraven
    Staci Horvath
    Ernest Bognar
    Neil Senzer
    Scott Brun
    John Nemunaitis
    Communications Medicine, 3